BCAN
Basic information
Region (hg38): 1:156641390-156659532
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (118 variants)
- not_provided (7 variants)
- High_myopia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BCAN gene is commonly pathogenic or not. These statistics are base on transcript: NM_000021948.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | |||||
| missense | 112 | 120 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 112 | 9 | 3 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| BCAN | protein_coding | protein_coding | ENST00000329117 | 13 | 18143 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00000176 | 1.00 | 125692 | 0 | 55 | 125747 | 0.000219 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.834 | 496 | 551 | 0.900 | 0.0000333 | 5744 |
| Missense in Polyphen | 189 | 252.56 | 0.74833 | 2586 | ||
| Synonymous | 0.154 | 233 | 236 | 0.987 | 0.0000145 | 1951 |
| Loss of Function | 3.48 | 17 | 41.1 | 0.414 | 0.00000218 | 447 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000274 | 0.000273 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00145 | 0.00131 |
| Finnish | 0.0000930 | 0.0000924 |
| European (Non-Finnish) | 0.000170 | 0.000167 |
| Middle Eastern | 0.00145 | 0.00131 |
| South Asian | 0.0000983 | 0.0000980 |
| Other | 0.000192 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in the terminally differentiating and the adult nervous system during postnatal development. Could stabilize interactions between hyaluronan (HA) and brain proteoglycans.;
- Pathway
- Spinal Cord Injury;Metabolism of carbohydrates;A tetrasaccharide linker sequence is required for GAG synthesis;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate biosynthesis;Dermatan sulfate biosynthesis;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;Extracellular matrix organization;Metabolism;Integrin;Degradation of the extracellular matrix;ECM proteoglycans
(Consensus)
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- loftool
- 0.734
- rvis_EVS
- -1.06
- rvis_percentile_EVS
- 7.58
Haploinsufficiency Scores
- pHI
- 0.281
- hipred
- Y
- hipred_score
- 0.541
- ghis
- 0.611
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.825
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bcan
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- skeletal system development;cell adhesion;central nervous system development;hippocampus development;extracellular matrix organization;chondroitin sulfate biosynthetic process;chondroitin sulfate catabolic process;dermatan sulfate biosynthetic process;synapse maturation
- Cellular component
- extracellular region;Golgi lumen;extracellular matrix;anchored component of membrane;lysosomal lumen;glutamatergic synapse
- Molecular function
- hyaluronic acid binding;carbohydrate binding